{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:50:16Z","timestamp":1760161816363},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,31]]},"DOI":"10.7759\/cureus.9494","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T13:19:44Z","timestamp":1596201584000},"source":"Crossref","is-referenced-by-count":4,"title":["Atypical Presentation of Myocardial Infarction in a Young Patient With Polycystic Ovarian Syndrome"],"prefix":"10.7759","author":[{"given":"Shobha","family":"Mandal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi  R","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mols Kowalczewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz R","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al.. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006, 91:4237-4245. 10.1210\/jc.2006-0178","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans FJ","year":"2006","unstructured":"Broekmans FJ, Knauff EA, Valkenburg O, et al.. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006, 113:1210-1217. 10.1111\/j.1471-0528.2006.01008.x","journal-title":"BJOG"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S107371","article-title":"Acute myocardial infarction in young women: current perspectives","volume":"10","author":"Chandrasekhar J","year":"2018","unstructured":"Chandrasekhar J, Gill A, Mehran R. Acute myocardial infarction in young women: current perspectives. Int J Womens Health. 2018, 10:267-284. 10.2147\/IJWH.S107371","journal-title":"Int J Womens Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren E","year":"1992","unstructured":"Dahlgren E, Janson PO, Johansson S, et al.. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 1992, 71:599-604. 10.3109\/00016349209006227","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot PC","year":"2011","unstructured":"de Groot PC, Dekkers OM, Romijn JA, et al.. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011, 17:495-500. 10.1093\/humupd\/dmr001","journal-title":"Hum Reprod Update"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif A","year":"1987","unstructured":"Dunaif A, Graf M, Mandeli J, et al.. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. J Clin Endocrinol Metab. 1987, 65:499-507. 10.1210\/jcem-65-3-499","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull MG","year":"1987","unstructured":"Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1987, 1:235-245. 10.3109\/09513598709023610","journal-title":"Gynecol Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran L","year":"2009","unstructured":"Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009, 15:477-488. 10.1093\/humupd\/dmp008","journal-title":"Hum Reprod Update"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3892\/br.2018.1149","article-title":"Serum homocysteine is associated with polycystic ovarian syndrome in Jordan","volume":"9","author":"Saadeh N","year":"2018","unstructured":"Saadeh N, Alfaqih MA, Mansour H, et al.. Serum homocysteine is associated with polycystic ovarian syndrome in Jordan. Biomed Rep. 2018, 9:439-445. 10.3892\/br.2018.1149","journal-title":"Biomed Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski SN","year":"2010","unstructured":"Tchaikovski SN, Rosing J. Mechanisms of estrogen-induced venous thromboembolism. Thromb Res. 2010, 126:5-11. 10.1016\/j.thromres.2010.01.045","journal-title":"Thromb Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede H","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010, 8:41. 10.1186\/1741-7015-8-41","journal-title":"BMC Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9553","article-title":"Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis","volume":"7","author":"Zhao L","year":"2016","unstructured":"Zhao L, Zhu Z, Lou H, et al.. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget. 2016, 7:33715-33721. 10.18632\/oncotarget.9553","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36876-atypical-presentation-of-myocardial-infarction-in-a-young-patient-with-polycystic-ovarian-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:08Z","timestamp":1707506648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36876-atypical-presentation-of-myocardial-infarction-in-a-young-patient-with-polycystic-ovarian-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.9494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,31]]}}}